MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion
1. MIRA's Ketamir-2 shows strong efficacy in diabetic neuropathy animal model. 2. Subjects demonstrated complete symptom reversal, potentially enhancing MIRA's product pipeline.